Work

P2.03a-014 A Dose-Finding and Phase 2 Study of Ruxolitinib plus Pemetrexed/Cisplatin for Nonsquamous Non–Small Cell Lung Cancer (NSCLC)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.1223

Authors: Giuseppe Giaccone, Rachel Sanborn, Saiama Waqar, Alex Martinez, Santiago Ponce, Huiling Zhen, Gerard Kennealey, Susan Erickson-Viitanen, Eric Schaefer

Institutions: Georgetown University, Providence Portland Medical Center, Washington University in St. Louis, Vall d'Hebron Hospital Universitari, Incyte (United States), Highlands Oncology Group

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2571023104

FWCI:

Cites:

Cited by:

Related to: 10